Build in-house for your development loop. Buy eval as a service for independent, contamination-free, regulator-acceptable validation. Most teams need both, and the mistake is using one where you need the other.
If you lead engineering or own AI at your company, you have probably already stood up promptfoo, DeepEval, Ragas, or LangSmith. Good. The question is not whether those tools are worth using. It is what they can and cannot give you, and where the gap is expensive enough to pay someone else to close it.
TL;DR
- In-house eval tools are excellent for fast iteration and the developer loop. Keep them.
- They cannot give you independence: the team that built the system cannot be the team that validates it. This is structural, not a tooling gap.
- They also struggle with contamination-free corpora, clustered statistics, and evidence a regulator or board will accept.
- The hidden cost of evals is not tokens. Judging thousands of items costs tens of dollars. The cost is human judgment: assembling the corpus and aligning the rubric.
- Build for iteration. Buy for validation. Use the decision checklist below to decide which line you are on.
What do in-house eval tools do well?
They shorten the loop between a change and a signal. That is their whole job, and they are good at it.
Tools like promptfoo, DeepEval, Ragas, and LangSmith let you wire evals into CI, diff two prompt versions, catch obvious regressions, and see a pass rate on your own test set before you merge. When an engineer tweaks a system prompt or swaps a model, they get feedback in minutes. That tight loop is where most day-to-day quality is won.
For that use case, do not buy anything. Building it in-house is cheaper, faster, and closer to your code. You want these evals owned by the people writing the system, running on every PR.
What can’t you build in-house?
Four things, and they matter most exactly when the stakes are highest.
Independence. The team that built a system cannot objectively validate it. This is not about talent or integrity. It is the same principle behind SR 11-7 model risk guidance: validation must be functionally separate from development. An in-house eval written by the team shipping the feature inherits that team’s blind spots, its choice of test cases, and its definition of “good.”
A contamination-free corpus. Public benchmarks leak into training data. Reused internal test sets leak into prompt tuning. Once your team has seen the eval cases, those cases stop measuring generalization and start measuring memorization. Keeping a corpus genuinely held out, and proving it, is hard when the same people build and test.
Clustered statistics. A pass rate is not a result. If you run 500 items drawn from 40 real conversations, those items are correlated, and naive per-item confidence intervals will overstate your certainty. Most in-house harnesses report a raw number with no error bars and no clustering. That is how teams ship a “3 point improvement” that is inside the noise.
Evidence someone else will accept. Your own dashboard convinces your own team. It does not convince a regulator, an enterprise procurement reviewer, or a board risk committee. Those audiences want a methodology they did not design, run by a party that does not benefit from the result, mapped to a framework they recognize.
Isn’t the cost of evals mostly compute?
No, and this is the most common budgeting error.
The token cost of judging is tiny. Running an LLM judge over thousands of items typically costs tens of dollars. If your eval bill is dominated by inference, you are looking at the cheap part.
The real cost is human judgment. Someone has to assemble a corpus that reflects your actual traffic, define what a correct trajectory or tool selection looks like, write and align the rubric, and then check that the judge agrees with expert humans often enough to trust it. That work is skilled, slow, and does not get cheaper because you bought a tool. When people say evals are expensive, this is what they are paying for.
When should you build vs buy?
Build when the eval is part of your development loop, changes daily, and only your team needs to trust it. Iteration speed and code proximity win.
Buy when you need a result that is independent, held out, statistically honest, and acceptable to someone outside your team. Independence and evidence win, and neither is something you can build for yourself by definition.
Concretely, buy when you are choosing between models for a high-stakes deployment, validating an agent before it touches money or customers, answering a regulator under RBI, the EU AI Act, or SR 11-7, or when a customer’s procurement team is asking how you know your AI works. Our method is built around producing exactly that kind of evidence inside your own VPC, so your data never leaves your control.
How does the comparison actually break down?
| Dimension | In-house tools (promptfoo, DeepEval, Ragas, LangSmith) | Eval as a service |
|---|---|---|
| Best for | Dev loop, CI regression checks, fast iteration | Independent validation, high-stakes go/no-go |
| Independence | None (builders grade themselves) | Structural (separate party validates) |
| Corpus | Reused, exposed to the team over time | Held out, contamination-controlled |
| Statistics | Usually raw pass rate, no clustering | Clustered CIs, powered comparisons |
| Compliance evidence | Not regulator-acceptable | Framework-mapped report |
| Setup cost | Low, you own the code | Engagement, but no infra to maintain |
| Speed | Minutes per run | Days per validation cycle |
| Data control | In your environment | In your VPC (with the right provider) |
Neither column is “better.” They answer different questions. The failure mode is presenting an in-house pass rate as if it were a validation, or spinning up a service engagement to catch a typo in a prompt.
What’s the decision checklist?
Ask these in order. If you answer yes to any of the second group, you are in buy territory for that specific decision.
Build territory:
- Does this eval run on every PR to catch regressions?
- Is the audience only your own engineers?
- Does it change as fast as your code does?
Buy territory:
- Will the result gate a high-stakes launch (money, safety, customers at scale)?
- Does anyone outside your team need to trust it (regulator, board, procurement)?
- Do you need to prove the test set was not contaminated?
- Are you comparing models or vendors where the loser has an incentive to dispute the method?
- Are you evaluating agent trajectories or MCP tool selection, where correctness is about the path, not just the final answer?
If your work is agent-heavy, that last point is where in-house harnesses tend to be weakest. Measuring whether an agent picked the right tool and took a defensible path is a different discipline from scoring a single output. We wrote about the buyer’s side of that in why independent LLM evaluation matters, and about keeping the whole thing inside your perimeter in in-VPC LLM evaluation.
FAQ
Can’t we just hire a separate internal team to get independence? It helps, but it is weaker than external validation. An internal team still shares incentives, leadership, and often the same test data lineage. For regulated or high-stakes cases, reviewers specifically want a party that does not benefit from the outcome. You can read how we structure that separation on our field page.
We already pay for LangSmith. Isn’t that eval as a service? LangSmith and similar platforms are excellent tooling that you operate. That is still in-house evaluation: your team designs the tests, picks the cases, and reads the results. Eval as a service means an independent party owns the methodology and the held-out corpus, and produces a report you did not author.
Are LLM-judge scores reliable enough to bet on? For relative comparisons with a pinned judge and a validated rubric, yes. For absolute scores read off a single run, no. The reliability comes from the human alignment work behind the judge, not the judge model itself, which is again why the cost is labor and not tokens.
How big does a corpus need to be? Big enough to detect the effect you care about, accounting for clustering. A few hundred well-chosen, held-out items with proper statistics beats thousands of correlated, exposed ones. Sizing is a power question, not a “more is better” question.
Most teams should build for the loop and buy for the decisions that carry real risk. If you have a launch, a model choice, or a compliance deadline coming and want to know where you actually stand, book a free eval diagnostic and we will map it out with you.